Logo image of MBWS.PA

MARIE BRIZARD WINE & SPIRITS (MBWS.PA) Stock Fundamental Analysis

Europe - EPA:MBWS - FR0000060873 - Common Stock

2.96 EUR
+0.05 (+1.72%)
Last: 10/15/2025, 7:00:00 PM
Fundamental Rating

3

MBWS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 29 industry peers in the Beverages industry. MBWS has a great financial health rating, but its profitability evaluates not so good. MBWS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MBWS was profitable.
MBWS had a positive operating cash flow in the past year.
In multiple years MBWS reported negative net income over the last 5 years.
In multiple years MBWS reported negative operating cash flow during the last 5 years.
MBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFMBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

MBWS has a Return On Assets (3.46%) which is in line with its industry peers.
MBWS's Return On Equity of 4.52% is on the low side compared to the rest of the industry. MBWS is outperformed by 75.86% of its industry peers.
With a Return On Invested Capital value of 3.24%, MBWS is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for MBWS is significantly below the industry average of 8.16%.
The 3 year average ROIC (3.06%) for MBWS is below the current ROIC(3.24%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROIC 3.24%
ROA(3y)2.1%
ROA(5y)-1.19%
ROE(3y)2.78%
ROE(5y)-9.35%
ROIC(3y)3.06%
ROIC(5y)2.16%
MBWS.PA Yearly ROA, ROE, ROICMBWS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 5.12%, MBWS is doing worse than 72.41% of the companies in the same industry.
In the last couple of years the Profit Margin of MBWS has grown nicely.
MBWS has a worse Operating Margin (4.72%) than 86.21% of its industry peers.
In the last couple of years the Operating Margin of MBWS has grown nicely.
Looking at the Gross Margin, with a value of 39.05%, MBWS is doing worse than 79.31% of the companies in the same industry.
MBWS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
MBWS.PA Yearly Profit, Operating, Gross MarginsMBWS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MBWS is destroying value.
Compared to 1 year ago, MBWS has about the same amount of shares outstanding.
MBWS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MBWS is higher compared to a year ago.
MBWS.PA Yearly Shares OutstandingMBWS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MBWS.PA Yearly Total Debt VS Total AssetsMBWS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

MBWS has an Altman-Z score of 4.24. This indicates that MBWS is financially healthy and has little risk of bankruptcy at the moment.
MBWS has a better Altman-Z score (4.24) than 86.21% of its industry peers.
MBWS has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
MBWS has a better Debt to FCF ratio (0.82) than 93.10% of its industry peers.
MBWS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, MBWS belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Altman-Z 4.24
ROIC/WACC0.41
WACC7.98%
MBWS.PA Yearly LT Debt VS Equity VS FCFMBWS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 2.71 indicates that MBWS has no problem at all paying its short term obligations.
MBWS has a Current ratio of 2.71. This is amongst the best in the industry. MBWS outperforms 89.66% of its industry peers.
MBWS has a Quick Ratio of 1.84. This is a normal value and indicates that MBWS is financially healthy and should not expect problems in meeting its short term obligations.
MBWS has a better Quick ratio (1.84) than 96.55% of its industry peers.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 1.84
MBWS.PA Yearly Current Assets VS Current LiabilitesMBWS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The earnings per share for MBWS have decreased strongly by -43.44% in the last year.
The Earnings Per Share has been growing by 11.49% on average over the past years. This is quite good.
The Revenue has decreased by -5.42% in the past year.
MBWS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.46% yearly.
EPS 1Y (TTM)-43.44%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-59.86%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-8.76%

3.2 Future

MBWS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
MBWS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.36% yearly.
EPS Next Y-12.5%
EPS Next 2Y-6.46%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year-5.32%
Revenue Next 2Y-1.61%
Revenue Next 3Y-0.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MBWS.PA Yearly Revenue VS EstimatesMBWS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
MBWS.PA Yearly EPS VS EstimatesMBWS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 59.20, MBWS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MBWS indicates a slightly more expensive valuation: MBWS is more expensive than 79.31% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.31. MBWS is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 41.46, MBWS can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, MBWS is valued a bit more expensive than 79.31% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MBWS to the average of the S&P500 Index (22.85), we can say MBWS is valued expensively.
Industry RankSector Rank
PE 59.2
Fwd PE 41.46
MBWS.PA Price Earnings VS Forward Price EarningsMBWS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

86.21% of the companies in the same industry are cheaper than MBWS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MBWS is valued a bit more expensive than the industry average as 68.97% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 35.7
EV/EBITDA 22.18
MBWS.PA Per share dataMBWS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.46%
EPS Next 3Y0%

0

5. Dividend

5.1 Amount

No dividends for MBWS!.
Industry RankSector Rank
Dividend Yield N/A

MARIE BRIZARD WINE & SPIRITS

EPA:MBWS (10/15/2025, 7:00:00 PM)

2.96

+0.05 (+1.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)09-25 2025-09-25
Earnings (Next)10-23 2025-10-23
Inst Owners5.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap331.49M
Analysts42.22
Price Target3.06 (3.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.29%
Valuation
Industry RankSector Rank
PE 59.2
Fwd PE 41.46
P/S 1.76
P/FCF 35.7
P/OCF 20.48
P/B 1.55
P/tB 2.66
EV/EBITDA 22.18
EPS(TTM)0.05
EY1.69%
EPS(NY)0.07
Fwd EY2.41%
FCF(TTM)0.08
FCFY2.8%
OCF(TTM)0.14
OCFY4.88%
SpS1.68
BVpS1.91
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROCE 3.98%
ROIC 3.24%
ROICexc 3.78%
ROICexgc 6.95%
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
FCFM 4.93%
ROA(3y)2.1%
ROA(5y)-1.19%
ROE(3y)2.78%
ROE(5y)-9.35%
ROIC(3y)3.06%
ROIC(5y)2.16%
ROICexc(3y)3.97%
ROICexc(5y)2.82%
ROICexgc(3y)8.7%
ROICexgc(5y)6.76%
ROCE(3y)3.76%
ROCE(5y)2.66%
ROICexcg growth 3Y30.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y42.22%
ROICexc growth 5YN/A
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Debt/EBITDA 0.5
Cap/Depr 144.28%
Cap/Sales 3.66%
Interest Coverage 250
Cash Conversion 118.37%
Profit Quality 96.28%
Current Ratio 2.71
Quick Ratio 1.84
Altman-Z 4.24
F-Score6
WACC7.98%
ROIC/WACC0.41
Cap/Depr(3y)199.06%
Cap/Depr(5y)172.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.44%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-59.86%
EPS Next Y-12.5%
EPS Next 2Y-6.46%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-8.76%
Revenue Next Year-5.32%
Revenue Next 2Y-1.61%
Revenue Next 3Y-0.36%
Revenue Next 5YN/A
EBIT growth 1Y10.35%
EBIT growth 3Y48.93%
EBIT growth 5YN/A
EBIT Next Year44.44%
EBIT Next 3Y18.56%
EBIT Next 5YN/A
FCF growth 1Y366.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y896.74%
OCF growth 3YN/A
OCF growth 5YN/A